Multiple genetic and epigenetic interacting mechanisms contribute to clonally selection of drug-resistant tumors: Current views and new therapeutic prospective-Reference-Cited by-同舟云学术

Multiple genetic and epigenetic interacting mechanisms contribute to clonally selection of drug-resistant tumors: Current views and new therapeutic prospective

Published:2006 Issue:3 Volume:207 Page:571-581
ISSN:0021-9541
Container-title:Journal of Cellular Physiology
language:en
Short-container-title:J. Cell. Physiol.

Author:

Roberti Annalisa,Sala Dario La,Cinti Caterina

Publisher

Wiley

Subject

Cell Biology,Clinical Biochemistry,Physiology

Reference102 articles.

1. The EORTC early clinical trials cooperative group experience with 5-aza-2′-deoxycytidine (NSC 127716) in patients with colo-rectal, head and neck, renal carcinomas and malignant melanomas

2. Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours

3. Histone acetylation and cancer

4. Role of hMLH1 promoter hypermethylation in drug resistance to 5-fluorouracil in colorectal cancer cell lines

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Correlation between small-cell lung cancer serum protein/peptides determined by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and chemotherapy efficacy;Clinical Proteomics;2024-05-19

2. The Identification of New c-FLIP Inhibitors for Restoring Apoptosis in TRAIL-Resistant Cancer Cells;Current Issues in Molecular Biology;2024-01-12

3. Natural Immunomodulators in Cancer Therapy;Natural Immunomodulators: Promising Therapy for Disease Management;2023-05

4. Immune Gene Therapy of Cancer;Handbook of Cancer and Immunology;2023

5. miR-30a attenuates drug sensitivity to 5-FU by modulating cell proliferation possibly by downregulating cyclin E2 in oral squamous cell carcinoma;Biochemistry and Biophysics Reports;2021-12